News and Announcements
Clevertar Wins Largest Contract to Date
- Published April 05, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- A leading federal government agency has engaged Clevertar to provide a high-quality Mental Health Coach for a cohort with mild-moderate anxiety and depression
- This will allow them access to therapy any time of the night or day, from anywhere in Australia.
Digital virtual assistant company, Clevertar, which is bringing virtual guides to healthcare for consumer impact at ‘a fraction of the cost of human intervention’, is excited to announce its largest contract to date. A leading federal government agency has engaged Clevertar to provide a high-quality Mental Health Coach for a cohort with mild-moderate anxiety and depression, allowing them access to therapy any time of the night or day, from anywhere in Australia. Authored by psychologists at Flinders University, Clevertar’s Mental Health Coach is a compelling demonstration of the power of Clevertar’s platform to engage consumers.
Clevertar’s CEO, Tanya Newhouse said, “The ability for enterprises to create and deliver all kinds of engaging content using virtual guides is really our platform’s core strength. The Mental Health coach is just one example, and I’m looking forward to seeing the many virtual guides that enterprises will create for their own unique purposes”.
About Clevertar Pty Ltd
Clevertar is an award-winning Australian technology company that brings behaviour changing ‘relational agents’ to healthcare. It has developed a SaaS platform for deployment of a range of digital coaches, which already includes coaches for type 2 diabetes, mental health, chronic pain and chronic heart failure.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
